A new drug for an old concept: aptamer to von Willebrand factor for prevention of arterial and microvascular thrombosis

被引：5
作者：
Veyradier, Agnes [1 ,2 ]
机构：
[1] Hosp Lariboisiere, AP HP Nord, French Natl Reference Ctr Thrombot Microangiopath, Hematol Dept, Paris, France
[2] Paris Univ, EA3548 St Louis Res Inst, Paris, France
来源：
HAEMATOLOGICA | 2020年 / 105卷 / 11期
关键词：
THROMBOCYTOPENIC PURPURA; PLATELET-FUNCTION; FACTOR A1-DOMAIN; DNA APTAMER; ARC1779; INHIBITION; EFFICACY; SAFETY; VIVO;
D O I：
10.3324/haematol.2020.261081
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2512 / 2515
页数：4
相关论文
共 28 条
[21]   High-density lipoprotein modulates thrombosis by preventing von Willebrand factor self-association and subsequent platelet adhesion [J].
Chung, Dominic W. ;
Chen, Junmei ;
Ling, Minhua ;
Fu, Xiaoyun ;
Blevins, Teri ;
Parsons, Scott ;
Le, Jennie ;
Harris, Jeff ;
Martin, Thomas R. ;
Konkle, Barbara A. ;
Zheng, Ying ;
Lopez, Jose A. .
BLOOD, 2016, 127 (05) :637-645
[22]   Trends in Translational Medicine and Drug Targeting and Delivery: New Insights on an Old Concept-Targeted Drug Delivery with Antibody-Drug Conjugates for Cancers [J].
Ho, Rodney J. Y. ;
Chien, Jenny .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 103 (01) :71-77
[23]   A dose ranging phase I/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with congenital thrombotic thrombocytopenic purpura [J].
Jilma-Stohlawetz, Petra ;
Gilbert, James C. ;
Gorczyca, Monika E. ;
Knoebl, Paul ;
Jilma, Bernd .
THROMBOSIS AND HAEMOSTASIS, 2011, 106 (03) :539-547
[24]   The Plasma Levels of ADAMTS-13, von Willebrand Factor, VWFpp, and Fibrin-Related Markers in Patients With Systemic Sclerosis Having Thrombosis [J].
Habe, Koji ;
Wada, Hideo ;
Higashiyama, Ayaka ;
Akeda, Tomoko ;
Tsuda, Kenshiro ;
Mori, Ryoko ;
Kakeda, Masato ;
Matsumoto, Takeshi ;
Ohishi, Kohshi ;
Yamanaka, Keiichi ;
Katayama, Naoyuki ;
Mizutani, Hitoshi .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 (06) :920-927
[25]   Novel aptamer to von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab [J].
Sakai, Kazuya ;
Someya, Tatsuhiko ;
Harada, Kaori ;
Yagi, Hideo ;
Matsui, Taei ;
Matsumoto, Masanori .
HAEMATOLOGICA, 2020, 105 (11) :2631-2638
[26]   von Willebrand Factor Predicts Mortality in ACS Patients Treated with Potent P2Y12 Antagonists and is Inhibited by Aptamer BT200 Ex Vivo [J].
Kovacevic, Katarina D. ;
Jilma, Bernd ;
Zhu, Shuhao ;
Gilbert, James C. ;
Winter, Max-Paul ;
Toma, Aurel ;
Hengstenberg, Christian ;
Lang, Irene ;
Kubica, Jacek ;
Siller-Matula, Jolanta M. .
THROMBOSIS AND HAEMOSTASIS, 2020, 120 (09) :1282-1290
[27]   High-Affinity DNA Aptamer Generation Targeting von Willebrand Factor A1-Domain by Genetic Alphabet Expansion for Systematic Evolution of Ligands by Exponential Enrichment Using Two Types of Libraries Composed of Five Different Bases [J].
Matsunaga, Ken-ichiro ;
Kimoto, Michiko ;
Hirao, Ichiro .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2017, 139 (01) :324-334
[28]   Stent thrombosis rates the first year and beyond with new- and old-generation drug-eluting stents compared to bare metal stents [J].
Varenhorst, Christoph ;
Lindholm, Martin ;
Sarno, Giovanna ;
Olivecrona, Goran ;
Jensens, Ulf ;
Nilsson, Johan ;
Carlsson, Jorg ;
James, Stefan ;
Lagergvist, Bo .
CLINICAL RESEARCH IN CARDIOLOGY, 2018, 107 (09) :816-823
123